Market Research Report : Hb a1c testing market in india 2013
•
3 likes•1,799 views
For the complete report, get in touch with us at : info@netscribes.com
Recommended
Recommended
More Related Content
Similar to Market Research Report : Hb a1c testing market in india 2013
Similar to Market Research Report : Hb a1c testing market in india 2013 (20)
More from Netscribes, Inc.
More from Netscribes, Inc. (20)
Recently uploaded
Recently uploaded (20)
Market Research Report : Hb a1c testing market in india 2013
- 1. Insert Cover Image using Slide Master View Do not distort HbA1c Testing Market IndiaHbA1c Testing Market – India July 2013
- 2. Executive Summary Market India is facing a persistent rise in its diabetic patient population and the number is estimated to grow from ‘u’ mn in 20‐‐ to ‘v’ mn in 20‐‐ HbA1c testing market in India is expected to reach INR ‘h1’ bn in 2017, growing at a CAGR of ‘ 1’ % f INR ‘b1’ b i 2012 i & Drivers Increase in the number of diabetics Challenges Test results can be influenced ‘x1’ % from INR ‘b1’ bn in 2012 Drivers & Challenges Growing need for diabetes diagnosis Increasing ageing population Comprehensive health insurance policies covering diabetics High price of tests Racial and ethnic variations in HbA1c results Technology Trends Latex Enhanced Immunoassay Method Enzymatic HbA1c Assay Method High‐Performance Liquid Chromatography Method Competitive Landscape Major Diagnostic Service Providers Apollo Health and Life Styles Ltd. Dr. Lal Path Labs Pvt. Ltd. Metropolis Healthcare Ltd. Major HbA1c Analyzer and Bio Rad Laboratories Trivitron Healthcare 2HbA1c TESTING MARKET IN INDIA 2013.PPT p Major HbA1c Analyzer and Reagent Manufacturers Abbott India Ltd. Bio‐Rad Laboratories (India) Pvt. Ltd. Trivitron Healthcare Pvt. Ltd.
- 4. Healthcare system in India requires a larger public outlay due to huge population base • According to “World Health Statistics 2011 Report, India”, healthcare comprised u% of India’s GDP in 2008 8,000 INR bn % Healthcare Market Size & GrowthHealthcare Industry Overview Public and private expenditure on health as percentage of GDP was v% and w% respectively • Favorable demographics, increase in awareness levels and better medical care are some factors that are driving the healthcare sector in India 0 2,000 4,000 6,000 , x% g f d cba driving the healthcare sector in India • Segment 1 comprise the largest segment of overall healthcare market, followed by pharmacy, medical equipment, diagnostics and healthcare IT • Gradual penetration of health insurance is stepping up 0 20‐‐e20‐‐e20‐‐e20‐‐e20‐‐e20‐‐ Healthcare Market‐ Segmentation affordability of health services through increased demand for preventive and curative healthcare services • Superior quality healthcare, coupled with low treatment costs in comparison to other countries, is b fitti I di di l t i th b d i i th y% p% Segment 3 Segment 2 Segment 1 benefitting Indian medical tourism, thereby driving the Indian healthcare market Treatment for major surgeries in India costs approximately 20% of that in developed countries t% s% r% q% Segment 6 Segment 5 Segment 4 4HbA1c TESTING MARKET IN INDIA 2013.PPT
- 5. Diagnostics labs are witnessing healthy growth on the backdrop of huge expansion & improvement in technology • Enhanced physician knowledge, coupled with better technology in the field of diagnostics, is causing the I di k 150 INR bn x% g f Diagnostic Service Market Size & GrowthDiagnostic Service – Market Overview Indian market to grow • Rise in lifestyle diseases has caused medical diagnostics market to grow immensely in tier II and tier III cities • Diagnostic market is characterized by the presence of large number of labs in the unorganized sector that are 0 50 100 f d c ba large number of labs in the unorganized sector that are not accredited 0 20‐‐e20‐‐e20‐‐e20‐‐e20‐‐e20‐‐ Diagnostic Service Market‐ Split Diagnostic Service Market‐ Segmentation n% q% m% p%India has more than u ‘000 labs 5HbA1c TESTING MARKET IN INDIA 2013.PPT Category 2Category 1 Segment 2Segment 1
- 6. Rising diabetic population of India will ensure steady growth of HbA1c testing • HbA1c market in India is expected to reach INR h1 bn in 20‐‐, growing at a CAGR of x1% from INR a1 bn in 20‐‐ • HbA1c tests can be offered exclusively or in packages with other tests by the diagnostic service providers HbA1c – Market Overview • Technology ‘A’ is currently the most common method adopted for conducting HbA1c tests in India • PoCT for HbA1c testing at the household level is not available in the domestic market and hence, the laboratories and hospitals offering HbA1c tests hold 100% market share • There is a growing level of awareness among the diabetic patient population of India about HbA1c testing which is leading them to take the test independently which in turn will suitably drive the HbA1c testing market in India Approximately u%‐v% of the HbA1c test takers come without the doctor’s recommendation HbA1c Market Size & Growth HbA1c Tests Conducted Annually INR bn 8 6 x1% h1 g1 f1 d1 15 mn x2% h2 g2 f2d26 4 2 0 f1 d1 c1 b1a1 0 5 10 d2c2b2 a2 6HbA1c TESTING MARKET IN INDIA 2013.PPT 20‐‐e20‐‐e20‐‐e20‐‐e20‐‐e20‐‐20‐‐ 20‐‐e20‐‐e20‐‐e20‐‐e20‐‐e20‐‐20‐‐
- 8. Rapidly growing pool of diabetic patients in the country will result in a continuous increase in the number of HbA1c tests • India is the second largest diabetic pool in the world, after China • Rapid urbanization and industrialization have led to lifestyle related changes that has increased Increase in the number of diabetics Impact the risk factors associated with diabetes High incidence of diabetes in India is mainly because of people’s sedentary lifestyles, lack of physical activity, obesity, stress and consumption of food rich in sugar, fat and calories From one generation to the next, the prevalence of diabetes has increased six fold Usually, u‐v% of diabetes cases are of type II and w‐z% are of type IUsually, u v% of diabetes cases are of type II and w z% are of type I • Number of diabetic patients is expected to increase at an exponential rate through the years which will result in a steady increase in the demand for HbA1c tests Increase in Diabetes Patients – India 60 80 mn y% hgfdcba 0 20 40 8HbA1c TESTING MARKET IN INDIA 2013.PPT 20‐‐e 20‐‐e20‐‐e20‐‐e20‐‐e20‐‐20‐‐ Note: The estimation covers diabetes in adult population between 20 years to 79 years
- 10. Diabetic retinopathy has been recently declared to be the 6th most prevalent cause of blindness Diabetic Retinopathy is a common diabetic eye disease that leads to blindness to both eyes caused by changes in the blood vessels of the retina Common Symptoms • People with diabetes (both type I and type II) are at risk and hence it is recommended to get a comprehensive dilated eye exam at least once a year • During pregnancy, diabetic retinopathy may be a problem for women with diabetes Common Symptoms Blood vessels may swell and leak fluid Abnormal new blood vessels grow on the surface of the retina Diabetic Retinopathy – Prevalence among Diabetics by Age mn 10 20 30 mn c7 b7 a7 c6 b6 a6 c5 b5 a5 c4 b4 a4 c3 b3 a3 c2 b2 a2 c1 b1 a1 t‐u yearsr‐s yearsp‐q years 10HbA1c TESTING MARKET IN INDIA 2013.PPT 0 20‐‐e20‐‐e20‐‐e20‐‐e20‐‐e20‐‐20‐‐
- 11. Technology Trends (1/3) : Technology 1 Method • The technology is also known as ‘Technology X’ • This method for HbA1c testing is based on interactions between Particle 1 and Particle 2 • The cross‐link reaction results in changes in solution turbidity which is proportional to the amount of antigen present in samples Latex Enhanced Immunoassay Method •The method has an advantage over ‘Technology A’ method in its application on general chemistry analyzer H h h d l k i i i d d d f P i l Y f i i h Method Analysis •However, the method lacks in precision standards and use of Particle Y often causes cuvette contamination that results in deterioration of assay precision 11HbA1c TESTING MARKET IN INDIA 2013.PPT
- 12. Market Competition – Porter’s Five Forces Analysis Threat of New Entrants Impact Impact Impact Bargaining Power of Suppliers Competitive Rivalry Bargaining Power of Buyers Impact Threat of Substitutes Impact 12HbA1c TESTING MARKET IN INDIA 2013.PPT
- 13. Competitive Benchmarking (1/4) Key Ratios of Major Companies – Operational Basis (FY 2012) (1/3) 500 % Net MarginOperating MarginGross Margin ‐500 0 500 f1d3 g2 f3 f2 c2 c3 c1 d2b3b2 a3 a2a1 ‐1,000 Company 6 g3 Company 5Company 4Company 3Company 2Company 1 • Company 1 recorded the highest gross margin, followed by Company 3 and Company 5 • Company 1 and Company 5 recorded similar operating margins with the former being slightly better than the latter • Company 6 and Company 3 recorded negative operating margin and net margin 13HbA1c TESTING MARKET IN INDIA 2013.PPT Note: Cost of Goods Sold for Dr Lal Pathlabs, S Serum and Thyrocare is N.A.
- 14. Private: Domestic Company – Company 1 (1/5) Company Information Offices and Centres – India Corporate Address Tel No. Fax No. Products and Services Website Year of Incorporation Head OfficeHyderabad Key People Category Products/Services Consultations Diagnostics N D i ti Heath Check Others Name Designation Person 1 CEO Person 2 Senior VP – Marketing Person 3 Head ‐ Operations and retails sales 14HbA1c TESTING MARKET IN INDIA 2013.PPT
- 15. Private: Domestic Company – Company 1 (2/5) Name No. of Shares held Bodies Corporate Shareholders of the Company as on 20/06/2012 Ownership Structure 100% Total 15HbA1c TESTING MARKET IN INDIA 2013.PPT Note: Ownership structure corresponds to Date of AGM:20/06/2012
- 16. i i l S h K i Private: Domestic Company – Company 1 (3/5) Financial Snapshot Key Ratios Net Profit/LossTotal Income INR mn 400 5 INR mn c2 a2 Particulars y‐o‐y change (2012‐11) 2012 2011 2010 2009 Profitability Ratios Operating Margin 0 ‐5 ‐10 400 300 200 100 5 d2 d1 c1 b2 a2 Net Margin Profit Before Tax Margin Return on Equity Return on Capital Employed Return on Working Capital Return on Assets Financial Summary ‐150 20122011 c1 2010 b1 2009 a1 Return on Fixed Assets Cost Ratios Operating costs (% of Sales) Administration costs (% of Sales) Interest costs (% of Sales) • The company incurred a net profit of INR X mn in FY 20XX, as compared to net profit of INR Y mn in FY 20YY • The company reported total Income of INR XX mn in FY 20XX, registering an increase of X per cent over FY 20YY ( ) Liquidity Ratios Current Ratio Cash Ratio Leverage Ratios Debt to Equity Ratio D bt t C it l R ti • The company earned an operating margin of X.X per cent in FY 20XX, an increase of X.X percentage points over FY 20YY • The company reported debt to equity ratio of X.XX in FY 20XX, a decrease of X.X per cent over FY 20YY Debt to Capital Ratio Interest Coverage Ratio Efficiency Ratios Fixed Asset Turnover Asset Turnover Current Asset Turnover 16HbA1c TESTING MARKET IN INDIA 2013.PPT Improved Decline Working Capital Turnover Capital Employed Turnover
- 17. Private: Domestic Company – Company 1 (4/5) Business Highlights Description News • Company 1 operates as a wholly owned subsidiary of the Company A Overview • Company 1 operates as a wholly owned subsidiary of the Company A • It has established a large network of ‘Brand A’ across India • ‘Brand A’ functions as an integrated model providing facilities for Specialist Consultation, Diagnostics, Preventive Health Checks and 24‐hour Pharmacy k f h ‘ ’ li i i l ll di i l di dh d h Diagnostics • Has a network of more than ‘u’ clinics operational all over India, including Andhra Pradesh, Assam, Bihar, Delhi, Gujarat, Haryana, Karnataka, Kerala, Madhya Pradesh, Orissa, Srinagar, Tamil Nadu, Uttar Pradesh and West Bengal • It has established state‐of‐the‐art Labs, which are equipped to handle diagnostics and imaging servicesservices HbA1c • The HbA1c test is included in Product 1, which also includes Blood Sugar fasting & Post Prandial, Lipid Profile, Urine Routine, S Creatinine, BP –Ht‐Wt‐ BMI, Diet Counselling and Consultation with Diabetologist Future Plans • Company 1 has plans of setting up similar clinics overseas in the near future 17HbA1c TESTING MARKET IN INDIA 2013.PPT
- 19. Thank you for the attention HbA1c Testing Market – India report is part of Research on India’s Healthcare Industry Series. For any queries or customized research requirements, contact us at: Ph 91 22 4098 7600 Follow us on: Phone: +91 22 4098 7600 E‐Mail: info@netscribes.com About Netscribes, Inc. Netscribes, Inc. is a knowledge‐consulting and solutions firm with clientele across the globe. The company’s expertise spans areas of , g g f g p y p p f investment & business research, business & corporate intelligence, content‐management services, and knowledge‐software services. At its core lies a true value proposition that draws upon a vast knowledge base. Netscribes, Inc. is a one‐stop shop designed to fulfil clients’ profitability and growth objectives. Disclaimer: This report is published for general information only Although high standards have been used in the preparation “Netscribes” is 19HbA1c TESTING MARKET IN INDIA 2013.PPT Disclaimer: This report is published for general information only. Although high standards have been used in the preparation, Netscribes is not responsible for any loss or damage arising from use of this document. This document is the sole property of Netscribes and prior permission is required for guidelines on reproduction.